NCT03878199 Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms Status TERMINATED Phase PHASE1/PHASE2
NCT03865589 Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome Status ACTIVE_NOT_RECRUITING Phase NA
NCT03849456 Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder Status TERMINATED Phase PHASE2
NCT03848832 Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome Status TERMINATED Phase PHASE3
NCT03575325 Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT03572764 CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03555955 A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 Status COMPLETED Phase PHASE1
NCT03533114 A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension Status COMPLETED Phase PHASE3
NCT03532035 Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia Status WITHDRAWN Phase PHASE2
NCT03485729 ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer Status TERMINATED Phase PHASE2
NCT03436953 A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease Status WITHDRAWN Phase PHASE2
NCT03393611 CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT03339401 The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation Status TERMINATED Phase PHASE2
NCT03339297 An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) Status COMPLETED Phase PHASE2
NCT03335267 Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia Status COMPLETED Phase PHASE2